APA

Awouters F., Niemegeers C. J., Van den Berk J., Van Neuten J. M., Lenaerts F. M., Borgers M., Schellekens K. H., Broeckaert A., De Cree J. & Janssen P. A. (19780218). Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. : Experientia.

Chicago

Awouters F, Niemegeers C J, Van den Berk J, Van Neuten J M, Lenaerts F M, Borgers M, Schellekens K H, Broeckaert A, De Cree J and Janssen P A. 19780218. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. : Experientia.

Harvard

Awouters F., Niemegeers C. J., Van den Berk J., Van Neuten J. M., Lenaerts F. M., Borgers M., Schellekens K. H., Broeckaert A., De Cree J. and Janssen P. A. (19780218). Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. : Experientia.

MLA

Awouters F, Niemegeers C J, Van den Berk J, Van Neuten J M, Lenaerts F M, Borgers M, Schellekens K H, Broeckaert A, De Cree J and Janssen P A. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. : Experientia. 19780218.